Use of IκB-kinase inhibitors in pain therapy

US8809358B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Martin Michaelis · Frankfurt, DE
• Olaf Ritzeler · Bad Soden, DE
• Gerhard Jaehne · Frankfurt, DE
• Karl Rudolphi · Mainz, DE
• Gerd Geisslinger · Frankfurt am Main, DE
• Hans-Georg Schaible · Frankfurt am Main, DE

Key dates

• Filing date: Nov 6, 2008
• Grant date: Aug 19, 2014
• Expiry date: Nov 20, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/444
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the use of IκB-kinase Inhibitors and methods for the prophylaxis and therapy for treating pain comprising administering such compounds.